Genbank References: capsid (p24)

Authors	Title	Citation	E-value	# in Gb	#Pts	ART	Source	Cloning	StudyType
Vibholm (2019)	Characterization of intact proviruses in blood and lymph node from HIV-infected individuals undergoing analytical treatment interruption	J Virol. 2019 Apr 3;93(8):e01920-18.	2.22e-154	475	5	ART	PBMC	SGS	Reservoir

Download sequences

Accession	IsolateName	Country	Coll Date	Clone	MolType	Source	Note	FirstAA	LastAA	MutList
MK169427	101-LN-10E1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169448	101-LN-10F16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169428	101-LN-10F7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,23*,51N,60R,75K,80*,83L,89R,100K,116R,117*,133*,137R,156R,173K,180D,184*,194S,206R,220R,222R,225S,230I
MK169486	101-LN-1A8	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169449	101-LN-1G16	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169450	101-LN-1I16	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169416	101-LN-1I20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,80*,83L,89R,117*,127R,137R,143K,167Q,180D,184*,194S,206R,225S,230I
MK169417	101-LN-1N18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	27	231	27G,83L,180D,194S,225S,230I
MK169451	101-LN-2H2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169487	101-LN-2I5	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169452	101-LN-2J17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169418	101-LN-2M5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169453	101-LN-3C15	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169419	101-LN-3E16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,60K,71K,80*,83L,116R,133*,143K,156R,162K,173K,180D,184*,194S,220R,225S,230I
MK169420	101-LN-4A3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169454	101-LN-5D2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169421	101-LN-5G18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,110A,180D,194S,225S,230I
MK169455	101-LN-5J24	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169422	101-LN-5K17	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169456	101-LN-5K20	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169457	101-LN-6A19	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169423	101-LN-6B9	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,23*,60E,80*,83L,96I,100K,101R,117*,133*,156R,180D,184*,194S,206R,225S,230I
MK169458	101-LN-6F22	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169424	101-LN-6F5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,18K,23*,46R,80*,83L,167Q,180D,184*,194S,206R,225S,230I
MK169425	101-LN-6P21	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,46R,75K,80*,83L,89R,100K,101R,116R,117*,133*,137R,143K,159K,162K,167Q,180D,184*,194S,206R,222R,223R,225S,230I
MK169459	101-LN-7B2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169460	101-LN-7H9	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169426	101-LN-7L10	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,60E,80*,83L,117*,133*,180D,194S,206R,225S,230I
MK169462	101-LN-8N20	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169461	101-LN-8N6	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169463	101-LN-9D13	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169470	101-PB-10G10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169471	101-PB-11I13	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169489	101-PB-12G22	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169472	101-PB-12O8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169473	101-PB-13O20	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169434	101-PB-14I3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169447	101-PB-14K5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169435	101-PB-14L1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169474	101-PB-15D6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169436	101-PB-15G15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,23*,80*,83L,89R,116R,117*,127K,133*,156R,180D,184*,194S,206R,220R,223R,225S,230I
MK169475	101-PB-16C10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169476	101-PB-16K14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169477	101-PB-17H12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169490	101-PB-19C6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169429	101-PB-1I5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,80*,83L,101R,116R,133*,180D,184*,194S,225S,230I
MK169478	101-PB-21D23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169479	101-PB-21E19	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169480	101-PB-21F22	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169438	101-PB-21F6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169439	101-PB-21K5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,23*,60R,61R,76K,80*,83L,116R,117*,156R,162K,167Q,180D,184*,194S,206R,225S,230I
MK169481	101-PB-22C13	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169440	101-PB-22E21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	17	231	17R,37L,83L,135L,180D,187D,194S,225S,230I
MK169441	101-PB-22F9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169442	101-PB-22H9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,80*,83L,117*,180D,194S,225S,230I
MK169482	101-PB-22L20	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169443	101-PB-22N10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169483	101-PB-23C14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169444	101-PB-23C6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,46R,80*,83L,110I,180D,194S,220R,222R,225S,230I
MK169445	101-PB-23L23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169484	101-PB-23N3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,225S,230I
MK169485	101-PB-24D16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169446	101-PB-24D2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,23*,46R,80*,83L,89R,100K,117*,127R,128K,133*,143K,156R,180D,181I,184*,194S,206R,222R,225S,230I
MK169464	101-PB-2N17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169488	101-PB-5F12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169465	101-PB-6J14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169430	101-PB-7C16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169466	101-PB-7E14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169467	101-PB-8C24	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169431	101-PB-8C9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169468	101-PB-8D23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169432	101-PB-8I23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,80*,83L,116R,137R,180D,184*,194S,225S,230I
MK169469	101-PB-8L3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169433	101-PB-9H15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,83L,180D,194S,225S,230I
MK169519	114-LN-11D1	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,116A,148V,149C,200N
MK169520	114-LN-11D17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169521	114-LN-11L23	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169522	114-LN-12H5	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169523	114-LN-13G14	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169535	114-LN-13J2	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,183T
MK169498	114-LN-13M22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,23*,27I,44A,46R,80*,83L,96I,97K,116A,133*,137R,148V,149C,156R,184*
MK169491	114-LN-1G18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,44A,60E,80*,81N,83L,89R,101R,116A,117*,148V,149C,184*,200N,214I,222K
MK169513	114-LN-2I22	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169514	114-LN-2K13	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169492	114-LN-2L1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,44A,80*,83L,116A,148V,149C,200N
MK169529	114-LN-3I3	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,183T
MK169515	114-LN-3M2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,116A,148V,149C,200N
MK169516	114-LN-3O21	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169530	114-LN-4O14	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169493	114-LN-6F22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,27I,83L,116A,148V,149C
MK169494	114-LN-7F13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,27I,44A,80*,83L,116A,128K,148V,149C,184*,214I,220R
MK169531	114-LN-7F24	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C
MK169495	114-LN-7G20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169496	114-LN-8D7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,23*,27I,44A,60K,80*,83L,89E,96I,100K,116A,117*,137R,148V,149C,184*,222E
MK169532	114-LN-8G10	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169533	114-LN-8H12	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C
MK169497	114-LN-8K12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,60K,80*,83L,89R,100K,116A,117*,137R,148V,149C,156R,184*,200N,220R,222R
MK169517	114-LN-9H13	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,116A,148V,149C
MK169518	114-LN-9L17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169534	114-LN-9O7	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169501	114-PB-10C3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,27I,44A,80*,83L,100K,116A,117*,148V,149C,156R,180K,184*,206R,222R,229K
MK169502	114-PB-10D2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C,156R
MK169525	114-PB-10G7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C
MK169503	114-PB-10G9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,44A,83L,96I,101R,116A,133*,148V,149C,156R,184*,200N,220R,222R
MK169536	114-PB-17H6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169504	114-PB-21C1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169537	114-PB-24F2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169505	114-PB-28D9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,44A,80*,83L,116A,137R,148V,149C,156R,200N,206R
MK169499	114-PB-2F7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169538	114-PB-30B6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169539	114-PB-31F11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169540	114-PB-39D10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169506	114-PB-53B1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C
MK169526	114-PB-57F10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169507	114-PB-60B1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,23*,44A,80*,83L,89R,116A,127R,148V,149C,162K,167Q,184*,200N,222R
MK169512	114-PB-64D8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169541	114-PB-64J16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,27I,44A,83L,116A,148V,149C
MK169508	114-PB-68O4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,23*,44A,83L,100K,116A,148V,149C,200N,206R
MK169524	114-PB-6C6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,27I,83L,116A,148V,149C,200N
MK169542	114-PB-71M5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169527	114-PB-73D19	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,116A,148V,149C,200N
MK169509	114-PB-73P17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,27I,44A,60R,83L,116A,148V,149C,184*
MK169543	114-PB-73P8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169510	114-PB-74B12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,44A,83L,116A,148V,149C,200N
MK169511	114-PB-74J14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,27I,44A,75K,80*,83L,89E,100K,116A,117*,133*,148V,149C,156R,184*,220R
MK169528	114-PB-74P6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,116A,148V,149C,200N,224S
MK169500	114-PB-8A12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,23*,27I,44A,75K,80*,83L,89E,100K,116A,117*,133*,148V,149C,156R,184*,220R
MK169617	116-LN-10A7	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169618	116-LN-10B12	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169563	116-LN-10B2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169619	116-LN-10B20	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169620	116-LN-10C8	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169668	116-LN-10I1	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169564	116-LN-10K15	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169621	116-LN-10K7	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169565	116-LN-10O11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169622	116-LN-12B23	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169669	116-LN-12C8	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169566	116-LN-12E2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169623	116-LN-12G2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169624	116-LN-12M2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169625	116-LN-12M20	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169626	116-LN-12O17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169567	116-LN-13B12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169568	116-LN-13E22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,8R,10I,14P,15L,23*,29K,44A,46R,52I,80*,83L,91V,96I,100K,101R,106K,116R,117*,118I,120S,127R,133*,134V,136I,137K,148V,154K,156R,162K,167Q,173K,175K,180D,184*,206R,220E,222R,223R,225S
MK169569	116-LN-13H20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,23*,44A,46R,52I,60R,80*,83L,91V,106R,120S,132G,133*,134V,136I,137R,148V,154K,162K,180D,184*,206R,225S
MK169627	116-LN-13I19	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169570	116-LN-13O16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169629	116-LN-13O21	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169628	116-LN-13O9	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169630	116-LN-14C23	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169571	116-LN-14F11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,96I,100K,116R,120S,132G,133*,134V,136I,137R,148V,154K,156R,162K,180D,184*,206R,225S
MK169631	116-LN-14H8	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,183T,225S
MK169632	116-LN-14J21	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169572	116-LN-14M5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,14P,15L,23*,44A,46R,52I,80*,83L,91V,96I,106R,120S,128D,132G,133*,134V,136I,148V,154K,156R,162K,180D,183T,184*,222R,225S
MK169573	116-LN-14N9	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,195S,225S
MK169574	116-LN-14O15	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169575	116-LN-15E14	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,14P,15L,23*,44A,46R,52I,60R,80*,83L,91V,100K,106R,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,220R,222R,225S
MK169576	116-LN-15N6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169577	116-LN-15O7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,225S
MK169546	116-LN-1E5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169547	116-LN-1G1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169548	116-LN-2A3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,29K,44A,46R,52I,61R,80*,83L,91V,106R,117*,120S,127E,128D,132G,133*,134V,136I,148V,154K,156R,162K,167Q,175K,180D,183T,184*,225S
MK169603	116-LN-2A5	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169604	116-LN-2E3	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169549	116-LN-2H1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169664	116-LN-3O14	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,123A,132G,134V,136M,148V,154K,180D,183T,225S
MK169605	116-LN-4B21	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169606	116-LN-4C20	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169552	116-LN-4G16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169553	116-LN-4J20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169607	116-LN-4O1	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169554	116-LN-5C21	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169555	116-LN-5E14	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169556	116-LN-5F8	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,14P,15L,23*,44A,46R,52I,60R,80*,83L,91V,100K,106R,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,220R,222R,225S
MK169608	116-LN-5G12	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169557	116-LN-5K17	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169665	116-LN-5K2	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,225S
MK169558	116-LN-5M20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,14P,15L,23*,44A,46R,52I,60E,80*,83L,91V,100K,106K,117*,120S,127R,128D,133*,134V,136M,137R,148V,154K,156R,162K,180D,183T,184*,206R,222R,225S
MK169559	116-LN-6J5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169610	116-LN-6P19	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169609	116-LN-6P4	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,225S
MK169611	116-LN-8B17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,225S
MK169612	116-LN-8F8	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169666	116-LN-8I10	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169560	116-LN-8M22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169613	116-LN-9A11	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169614	116-LN-9B13	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169667	116-LN-9B14	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169561	116-LN-9D14	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,23*,44A,46R,52I,80*,83L,91V,120S,123A,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169615	116-LN-9G10	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169616	116-LN-9L14	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169562	116-LN-9M23	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,60R,80*,83L,91V,148V,154K,162K,180D,184*,206R,225S
MK169641	116-PB-10C2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169642	116-PB-11G11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169598	116-PB-12G7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169582	116-PB-13F3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169583	116-PB-13F7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,23*,44A,83L,91V,106R,136I,156R,162K,180D,184*,225S
MK169643	116-PB-13G3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169670	116-PB-14B9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169644	116-PB-14C6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169645	116-PB-14G1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169646	116-PB-14H11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169599	116-PB-15C3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169647	116-PB-15C7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169600	116-PB-16G10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169584	116-PB-17E2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169671	116-PB-17F4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169601	116-PB-17H4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169585	116-PB-18G9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,184*,225S
MK169602	116-PB-18H4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169648	116-PB-19H10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169592	116-PB-1A10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169593	116-PB-1H1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169649	116-PB-20G7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169672	116-PB-23A6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169586	116-PB-24D1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169650	116-PB-27E11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169673	116-PB-28B1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169651	116-PB-28D9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169652	116-PB-31B7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169653	116-PB-31D8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169654	116-PB-32F10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169587	116-PB-33A5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169655	116-PB-33F3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169656	116-PB-34E4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,148V,154K,180D,225S
MK169674	116-PB-34G12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	3I,6L,14P,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169657	116-PB-34G6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	3I,6L,14P,15L,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,183T,225S
MK169658	116-PB-36G1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169588	116-PB-36H7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169659	116-PB-38A9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169675	116-PB-38E2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169589	116-PB-38E6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169578	116-PB-3A3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169660	116-PB-40D7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169676	116-PB-41B5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,44A,46R,52I,83L,91V,132G,134V,148V,154K,180D,183T,225S
MK169661	116-PB-42F8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169590	116-PB-45C4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169591	116-PB-45F12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,44A,46R,52I,83L,91V,120S,132G,134V,136M,148V,154K,180D,225S
MK169662	116-PB-46E9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169579	116-PB-4E10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169633	116-PB-4E12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169634	116-PB-6B7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169594	116-PB-6C10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169595	116-PB-6D4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169635	116-PB-6F6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169636	116-PB-8A9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169580	116-PB-8B2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169596	116-PB-8C1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169637	116-PB-8C5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169638	116-PB-8G8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169639	116-PB-9B12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169581	116-PB-9C10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169597	116-PB-9G6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169640	116-PB-9H8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,14P,15L,44A,83L,91V,136M,148V,154K,180D,225S
MK169545	116-PB-P12-E12-Nov-14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,44A,83L,91V,136M,180D
MK169663	116-PB-P4-G10-Nov-14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,14P,15L,44A,46R,52I,83L,91V,120S,128D,132G,134V,136M,148V,154K,180D,183T,225S
MK169544	116-PB-P6-H9-Nov-14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,14P,15L,23*,44A,46R,52I,80*,83L,91V,100K,101R,106R,120S,128D,132G,133*,134V,136I,148V,154K,162K,180D,183T,222R,225S
MK169678	120-LN-10-B4	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,83L,110N,116A
MK169731	120-LN-100G13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,83L,110N,116A,148I
MK169797	120-LN-101B16	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,83L,110N
MK169733	120-LN-101C22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,60E,80*,83L,89E,100K,101R,110N,116A,117*,133*,137R,143K,148I,156R,167Q,184*,206R,220R,222R,223R,225S
MK169732	120-LN-101C3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,60R,80*,83L,100K,110N,116A,133*,143K,148I,156R,184*,225S
MK169734	120-LN-101E13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,80*,83L,110N,116A,117*,127E,133*,143K,148I,156R,167Q,184*,206R,208G,220R,222R,223R
MK169735	120-LN-101G8	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169736	120-LN-101P16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,80*,83L,89R,101R,106R,110N,116A,117*,133*,137R,143K,156R,175K,184*,220R,229K
MK169737	120-LN-102F13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,27I,81N,82K,83L,101E,110N,116A,117*,133*,137E,148I,159K,180K,184*,208G
MK169738	120-LN-102L5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,27I,60K,61R,80*,83L,89R,96I,101R,110N,116A,117*,127R,133*,143K,144I,148I,156R,167Q,184*,206R,208G,220R,222R,225S
MK169798	120-LN-102N7	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,83L,110N,116A,160S,225S
MK169739	120-LN-103C18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,45K,60R,80*,83L,100K,110N,116A,117*,133*,137R,143K,156R,167Q,184*,222R,223R
MK169740	120-LN-103F6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,60E,80*,83L,96I,100K,101R,110N,116A,117*,133*,137R,167Q,184*,206R,222R,223R,225S
MK169741	120-LN-103N13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,110N,116A,117*,148I,156R,184*,208G
MK169742	120-LN-103O7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,80*,83L,110N,116A,148I,156R,206R,222R
MK169743	120-LN-104B10	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,46R,71K,75K,80*,83L,89R,96I,101R,110N,116A,117*,127R,133*,143K,167Q,184*,206R,208G,220R
MK169744	120-LN-105D7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,60E,80*,83L,96I,110N,116A,117*,184*,206R,208G,222R
MK169799	120-LN-105E15	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169745	120-LN-105P19	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,27I,83L,110N,116A,148I
MK169746	120-LN-106I10	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,61R,80*,83L,96I,100K,110N,116A,117*,133*,156R,184*,206R,208R,222R
MK169800	120-LN-106I8	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,99S,110N,116A,148I
MK169747	120-LN-106J24	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,83L,110N,116A,148I
MK169748	120-LN-106P15	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,51N,60E,71K,80*,83L,96I,100K,110N,116A,127K,133*,137E,143K,156R,167Q,184*
MK169749	120-LN-107P4	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,60E,75K,80*,83L,110N,116A,117*,127R,133*,137R,143K,156R,184*,206R,222R
MK169805	120-LN-108C5	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,27I,83L,110N,116A,148I
MK169750	120-LN-108N10	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,97K,100K,110N,116A,117*,133*,137R,143K,148I,156R,167Q,173K,184*,222R,223R
MK169751	120-LN-108P5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,46R,60E,80*,83L,89R,101R,110N,116A,117*,133*,137R,143K,148I,162K,184*,206R,220R,222R,225S
MK169679	120-LN-14-G4	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,96I,101E,110N,116A,117*,133*,156R,177T,184*,208R,220R,223R
MK169684	120-LN-18E11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,80*,83L,96I,110N,116A,117*,127R,133*,184*,229K
MK169677	120-LN-2-A6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169812	120-LN-2-D7	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169685	120-LN-21F1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,60E,80*,83L,101R,110N,116A,117*,133*,156R,184*,208G,220R,222R
MK169686	120-LN-21H3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,96I,110N,116A,117*,208G,225S
MK169687	120-LN-22D2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,60K,80*,83L,89R,96I,101R,110N,116A,117*,133*,167Q,208G
MK169688	120-LN-22G3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,27I,29K,46R,80*,83L,89R,110N,116A,117*,133*,137R,143K,148I,156R,184*,225S
MK169689	120-LN-29E3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,96I,101R,110N,116A,133*,156R,184*,208E,212K
MK169690	120-LN-29F1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,110N,116A,117*,148I,156R,184*,208G
MK169691	120-LN-29G9	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,60E,75K,80*,83L,100K,110N,116A,117*,184*,222R,223R,229K
MK169692	120-LN-31D5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,60K,80*,82K,83L,110N,117*,127R,137R,143K,173K,184*,223R
MK169787	120-LN-37C1	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169693	120-LN-38E3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,71K,80*,83L,89R,100K,110N,116A,117*,133*,156R,162K,163N,173K,184*,222R
MK169694	120-LN-38E6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,50Q_I*TQAFSPEVILMFTALSEGATPQ,80*,83L,100K,110N,116A,117*,127R,133*,184*,208R
MK169695	120-LN-42C12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,80*,83L,96I,110N,116A,117*,127R,133*,143K,156R,184*,206R,208G,220R,222R,229K
MK169696	120-LN-43A2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,89R,100K,110N,116A,117*,137R,143K,148I,184*,222R,223R
MK169697	120-LN-43C12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,28K,41T,46R,60R,71K,80*,83L,89R,100K,101R,106R,110N,116T,117*,128K,137R,143K,156R,167Q,173K,184*,198Y,206R,208E,222R,225S,229K
MK169698	120-LN-43D6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,110N,116A,117*,148I,156R,184*,208G
MK169699	120-LN-44G2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,80*,83L,100K,106R,110N,116A,117*,133*,184*,208T,220R,222R,223R,225S,229K
MK169700	120-LN-46C11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,110N,116A,117*,127R,128K,133*,137R,148I,156R,184*,208G,222R,223R,230I
MK169701	120-LN-48E4	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,100K,110N,116A,117*,127R,148I,184*,208G
MK169702	120-LN-49A2	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,60E,80*,83L,89R,96I,98K,100K,101R,106R,110N,116A,117*,133*,137R,143K,148I,156R,175K,184*,220R,222R,223R,229K
MK169703	120-LN-49B9	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,51N,80*,83L,110N,116A,117*,133*,148I,156R,206R,208G
MK169704	120-LN-50F12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,80*,82K,83L,110N,116A,117*,133*,137R,148I,184*,225S
MK169705	120-LN-51D5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,60R,80*,83L,100K,110N,116A,137R,156R,184*,208G,222R
MK169816	120-LN-54H1	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169706	120-LN-61C6	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,60R,80*,83L,100K,110N,116A,117*,137R,156R,184*,208G
MK169788	120-LN-61D4	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,27I,83L,110N,116A,148I,208G
MK169707	120-LN-62C7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,28K,46R,55I,60R,61R,79K,80*,83L,89R,101R,110N,116A,117*,133*,137R,143K,148I,156R,162K,184*,206R,208G,220R,222E,223R,229K
MK169708	120-LN-62H1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,60K,75K,80*,83L,100K,101R,110N,116A,117*,133*,137R,148I,156R,162K,184*,214I,220R,222R,225S
MK169789	120-LN-69H4	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169817	120-LN-70H2	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169790	120-LN-71C9	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,83L,110N,116A,225S
MK169709	120-LN-73H4	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,46R,60R,80*,83L,96I,101R,106R,110N,116A,117*,133*,143K,156R,184*,206R,208G,222R
MK169710	120-LN-75G10	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,83L,110N,116A,148I
MK169791	120-LN-76F7	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169818	120-LN-77D7	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169711	120-LN-77F3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,80*,83L,101R,110N,116A,208G
MK169713	120-LN-84B8	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,60R,71K,75K,80*,82K,83L,89K,96I,100K,101K,102N,106R,110N,116A,117*,133*,143K,156R,162K,184*,222R
MK169819	120-LN-85D2	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,27I,83L,110N,116A,148I,225S
MK169714	120-LN-85F12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169715	120-LN-86D9	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,71K,80*,83L,89R,100K,110N,116A,117*,133*,156R,162K,163N,173K,184*,222R
MK169716	120-LN-92C12	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,41T,80*,83L,89R,101R,106R,110N,116A,117*,133*,137R,143K,156R,175K,184*,220R,229K
MK169717	120-LN-93D11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,100K,110N,116A,117*,148I,184*
MK169803	120-LN-94A16	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169718	120-LN-94F22	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,46R,80*,83L,100K,110N,116A,117*,143K,167Q,173K,184*,223R
MK169719	120-LN-94K24	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,27I,29K,46R,71K,80*,83L,89R,106R,110N,116A,117*,133*,137R,143K,148I,156R,167Q,184*,222R,223R
MK169796	120-LN-95G19	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169720	120-LN-95I18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169721	120-LN-95L15	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169722	120-LN-96J17	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,100K,110N,116A,133*,156R,167Q,184*
MK169724	120-LN-96O1	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,18K,23*,27I,80*,83L,110N,116A,117*,128K,133*,148I,156R,162K,167Q,184*,208G,212K,229K
MK169804	120-LN-97E14	USA	2018		genomic RNA	lymph node CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169725	120-LN-97G24	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,60R,80*,83L,101R,103N,106E,110N,116A,117*,128K,133*,143K,148I,156R,167Q,173K,175K,184*,206R,220R,222R,225S,229K
MK169726	120-LN-97N20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,89R,97K,98K,101R,110N,116A,117*,148I,156R,184*,206R,208G,220R,221I,225S
MK169727	120-LN-98F11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,60K,80*,83L,89R,96I,101R,110N,116A,117*,133*,137R,143K,148I,156R,167Q,184*,225S,229K
MK169728	120-LN-99A7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169729	120-LN-99F16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,80*,83L,97K,110N,116A,117*,127R,133*,148I,162K,173K,184*,206R,208G,223R
MK169730	120-LN-99M5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,46R,80*,83L,100K,110N,116A,117*,133*,143K,184*,208G,222R,223R,229K
MK169813	120-PB-1-H6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,83L,110N,116A,225S
MK169815	120-PB-13-A3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,83L,110N
MK169683	120-PB-14-C3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169752	120-PB-15G7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,60R,80*,83L,110N,116A,133*,137R,148I,184*,223R,229K
MK169794	120-PB-16B5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169820	120-PB-16C5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169753	120-PB-17C11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,89R,110N,116A,117*,148I,156R,184*,206R,208G
MK169821	120-PB-18B7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169680	120-PB-2-D9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,110N,116A,117*,148I,156R,184*,208G
MK169754	120-PB-21F10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,82K,83L,96I,101R,110N,116A,117*,133*,143K,156R,184*,222R
MK169755	120-PB-21G11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,100K,101R,106R,110N,117*,133*,143K,167Q,184*,220R,222E
MK169756	120-PB-21G12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169757	120-PB-22H8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,80*,83L,110N,116A,206R,208G
MK169758	120-PB-23A9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169822	120-PB-24A8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169823	120-PB-24C4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169759	120-PB-25C1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,23*,27I,80*,82K,83L,89R,100K,110N,116A,133*,148I,184*
MK169795	120-PB-26D6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,27I,83L,110N
MK169760	120-PB-27B8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,60E,80*,83L,97K,110N,116A,133*,148I,206R,208G
MK169792	120-PB-3-D2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169681	120-PB-3-E4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,83L,100K,110N,116A,143K,148I,184*,206R,220R,222R,225S
MK169761	120-PB-31B21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169824	120-PB-31D23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169825	120-PB-31F14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169826	120-PB-31I13	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169762	120-PB-32B1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,60E,80*,83L,96I,100K,101R,110N,116A,117*,133*,137R,167Q,184*,206R,222R,223R,225S
MK169827	120-PB-32B12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169763	120-PB-34A9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,60R,80*,81N,83L,110N,116A,117*,127R,148I,156R,175K,184*,206R,208G,225S
MK169764	120-PB-35P5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169765	120-PB-36H8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,27I,83L,110N,116A,148I
MK169828	120-PB-37D20	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169766	120-PB-37K11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,80*,83L,96I,110N,116A,117*,208G
MK169829	120-PB-37K16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169830	120-PB-38F17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169767	120-PB-38H8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,29K,41T,75K,81N,82K,83L,96I,110N,116A,133*,137E,143K,166N,184*,185I,214I
MK169831	120-PB-38M3	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169832	120-PB-39A17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169814	120-PB-4-B1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169768	120-PB-40M10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,41T,80*,83L,89R,96I,101R,110N,116A,117*,133*,184*,208G
MK169769	120-PB-41H16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,60R,80*,83L,89R,96I,110N,116A,133*,137R,143K,156R,167Q,184*,206R
MK169770	120-PB-41J24	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,27I,46R,51N,60R,61R,80*,83L,89R,96I,100K,110N,116A,117*,127R,133*,137R,143K,148I,156R,167Q,184*,206R,208E,220R,222R,223K,229K
MK169801	120-PB-42I1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169771	120-PB-42I23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,60R,80*,83L,100K,110N,116A,117*,133*,143K,148I,156R,184*,206R,208E,220R,222R
MK169772	120-PB-42N7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,80*,83L,110N,116A,148I,208G
MK169773	120-PB-43B4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,110N,116A,117*,133*,148I,156R,184*,208G
MK169806	120-PB-44E5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169774	120-PB-44J8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,89R,96I,100K,101R,110N,116A,167Q,184*,198Y,206R,222R
MK169775	120-PB-44K18	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,79K,80*,83L,100K,110N,116A,133*,148I,162K,175K,184*,229K
MK169807	120-PB-44O4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169777	120-PB-45G15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169776	120-PB-45G5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,10I,15L,23*,41T,46R,51N,60R,71K,80*,83L,89R,96I,97K,100K,101R,110N,116A,117*,127K,128K,133*,137R,143K,144I,156R,165I,167Q,173K,184*,206R,208G,212K,214I,220R,222R,223R,229K
MK169778	120-PB-45J17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,27I,46R,80*,83L,110N,116A,117*,148I,156R,184*,208G
MK169779	120-PB-45K15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,10I,15L,41T,83L,96I,100K,110N,116A,156R,220R
MK169808	120-PB-45P8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169780	120-PB-48E8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169781	120-PB-48O4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A,208G
MK169809	120-PB-48P11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,48I,83L,110N,116A
MK169810	120-PB-49A21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169782	120-PB-49G1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,89R,96I,110N,116A,117*,133*,156R,167Q
MK169682	120-PB-5-C1	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,110N,116A
MK169793	120-PB-5-C8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169783	120-PB-50H6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,8R,15L,23*,27I,60E,80*,83L,110N,116A,143K,160S,184*,220R,225S
MK169784	120-PB-51I16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,121H
MK169785	120-PB-51K5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A,208G
MK169802	120-PB-52G19	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169811	120-PB-52P23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,110N
MK169786	120-PB-53C10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6L,15L,23*,41T,80*,83L,96I,100K,110N,116A,117*,208G,229K
MK169833	120-PB-53D2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6L,15L,41T,83L,96I,110N,116A
MK169874	LFSA-LN-11F19	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14S,15L,41T,80*,83L,91V,100K,120H,148S,154K,180D,184*,222E
MK169840	LFSA-LN-11G16	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169839	LFSA-LN-11G3	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169841	LFSA-LN-12I8	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169842	LFSA-LN-13C3	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,180D
MK169875	LFSA-LN-15B14	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,46R,80*,83L,87Q,91V,106R,116R,120H,127R,128D,148S,154K,180D,184*,206R,222R
MK169843	LFSA-LN-15D5	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,148S,154K,180D
MK169844	LFSA-LN-15N7	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169864	LFSA-LN-18F2	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169893	LFSA-LN-19F16	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,46R,80*,83L,91V,96I,116R,120H,127R,128D,148S,154K,180D,206R,220R
MK169865	LFSA-LN-19H14	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169894	LFSA-LN-19O13	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,8R,14P,15L,23*,41T,80*,83L,91V,120H,128D,143K,149C,154K,156R,180D
MK169835	LFSA-LN-2G10	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169866	LFSA-LN-2G8	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,41T,76K,83L,91V,120H,128D,148S,154K,162K,180D,213K,214I
MK169834	LFSA-LN-2G9	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169867	LFSA-LN-2H7	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,18K,28K,29K,41T,46E,51N,71K,75K,76K,81N,82K,83L,91V,96I,97K,101E,106E,117*,118I,120H,128D,132K,133*,137K,148S,154K,156E,159K,173K,180D,184*,187K,206E,212K,213K,214I,215I,220K,222K,223E,225R,229K
MK169868	LFSA-LN-3C20	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,41T,76K,83L,91V,120H,128D,148S,154K,162K,180D,213K,214I
MK169836	LFSA-LN-3P14	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169870	LFSA-LN-3P18	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,80*,83L,87Q,91V,100K,117*,120H,127R,128D,148S,154K,156R,180D
MK169869	LFSA-LN-3P3	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,128D,154K,180D
MK169871	LFSA-LN-6P5	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,10I,14P,23*,41T,80*,83L,91V,101R,111F,116R,120H,125L,127R,128D,137R,148S,154K,156R,180D,184*
MK169837	LFSA-LN-7C17	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169838	LFSA-LN-7O16	USA	2018		genomic RNA	lymph node CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D,225A
MK169872	LFSA-LN-8F14	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,46R,71K,80*,83L,89R,91V,96I,100K,101R,116R,120H,127K,128D,133*,137R,148S,154K,167Q,180D,184*,206R
MK169873	LFSA-LN-8P11	USA	2018		genomic RNA	lymph node CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,180D
MK169858	LFSA-PB-10B23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169886	LFSA-PB-10I14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,24X,41T,83L,91V,120H,128D,148S,154K,180D
MK169859	LFSA-PB-10M22	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169860	LFSA-PB-11C23	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,146C,148V,154K,180D
MK169887	LFSA-PB-11F14	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14S,15L,23*,41T,46K,80*,83L,89R,91V,100K,101E,116R,117*,120H,127E,133*,137R,143K,148S,154K,180D
MK169888	LFSA-PB-11M6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,47T,81N,83L,91V,116E,120H,128N,132K,133*,137E,148S,154K,166N,180D,206K,220E,223E
MK169861	LFSA-PB-12A4	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,87Q,91V,120H,128D,148S,154K,180D
MK169889	LFSA-PB-12C6	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,41T,81N,82K,83L,91V,96I,117*,120H,128D,137E,148S,154K,166N,180D,184*,206K,214I,225R,229K
MK169862	LFSA-PB-12H9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,128D,154K,180D
MK169863	LFSA-PB-12M15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,148S,154K,180D,225A
MK169890	LFSA-PB-13B11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,8K,10I,14P,15L,23*,41T,45K,60E,80*,82K,83L,91V,100K,116R,117*,120H,127K,133*,137R,143K,144I,146C,148V,154K,156R,162K,167Q,180D,184*,206R,214I,220K,222R,223R,225K
MK169895	LFSA-PB-14E24	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,83L,91V,100K,120H,127K,128D,133*,137R,148S,154K,156R,180D,206R,225R
MK169876	LFSA-PB-2G21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,97K,120H,148V,154K,180D,184*
MK169845	LFSA-PB-3C10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,180D
MK169877	LFSA-PB-3F19	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,80*,83L,89R,91V,100K,101R,116R,117*,120H,127E,128D,148S,154K,180D,184*,206R,220R
MK169846	LFSA-PB-3G9	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169848	LFSA-PB-3P21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,180D
MK169847	LFSA-PB-3P7	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169849	LFSA-PB-4D16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169878	LFSA-PB-4E11	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169850	LFSA-PB-4F10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169851	LFSA-PB-4J16	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169879	LFSA-PB-4M12	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,76K,80*,83L,91V,100K,101E,116R,117*,120H,127E,128D,133*,148S,154K,180D,184*,225A
MK169852	LFSA-PB-4N19	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169880	LFSA-PB-4O8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,24X,41T,83L,91V,120H,128D,148S,154K,180D
MK169854	LFSA-PB-4P10	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,87Q,91V,120H,128D,148S,154K,180D
MK169853	LFSA-PB-4P2	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169881	LFSA-PB-5H5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,80*,83L,91V,116R,120H,127E,128D,148S,154K,180D,184*
MK169891	LFSA-PB-6B17	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169855	LFSA-PB-6F20	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,41T,83L,91V,120H,128D,148S,154K,180D
MK169882	LFSA-PB-6I13	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,24X,41T,83L,91V,120H,128D,148S,154K,180D
MK169883	LFSA-PB-6J15	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,15L,23*,41T,80*,83L,91V,120H,127R,154K,180D,225R
MK169856	LFSA-PB-7M24	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,165V_TGCIALPVFWT*NKDQRNLLETM*,180D
MK169857	LFSA-PB-7N8	USA	2018		genomic RNA	peripheral blood CD4+ T cell	intact genome;subtype: B	1	231	6M,14P,15L,41T,83L,91V,120H,154K,180D,230I
MK169884	LFSA-PB-8G21	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,8R,10I,14P,15L,23*,41T,80*,83L,91V,116R,120H,127E,133*,148S,154K,156R,180D,206R,225A
MK169892	LFSA-PB-8K22	USA	2018		genomic RNA	peripheral blood CD4+ T cell	genome with defective/mutated major splice donor(MSD) site;subtype: B	1	231	6M,14P,41T,83L,87Q,91V,120H,128D,148S,154K,180D
MK169885	LFSA-PB-9K5	USA	2018		genomic RNA	peripheral blood CD4+ T cell	defective genome;subtype: B	1	231	6M,14P,23*,41T,83L,91V,116R,120H,137R,146C,148V,154K,180D